Advanced search

Cost-effectiveness analysis of current first-line drug regimens for visceral leishmaniasis

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Vanlerberghe, Veerle, S Gerstl, P Guerin, F Meheus, G Diap, Patrick Van Der Stuyft, and Marleen Boelaert. 2005. “Cost-effectiveness Analysis of Current First-line Drug Regimens for Visceral Leishmaniasis.” In Medicine and Health in the Tropics : Abstract Book, 81–82.
APA
Vanlerberghe, Veerle, Gerstl, S., Guerin, P., Meheus, F., Diap, G., Van Der Stuyft, P., & Boelaert, M. (2005). Cost-effectiveness analysis of current first-line drug regimens for visceral leishmaniasis. Medicine and health in the tropics : abstract book (pp. 81–82). Presented at the Medicine and Health in the Tropics.
Vancouver
1.
Vanlerberghe V, Gerstl S, Guerin P, Meheus F, Diap G, Van Der Stuyft P, et al. Cost-effectiveness analysis of current first-line drug regimens for visceral leishmaniasis. Medicine and health in the tropics : abstract book. 2005. p. 81–2.
MLA
Vanlerberghe, Veerle, S Gerstl, P Guerin, et al. “Cost-effectiveness Analysis of Current First-line Drug Regimens for Visceral Leishmaniasis.” Medicine and Health in the Tropics : Abstract Book. 2005. 81–82. Print.
@inproceedings{340069,
  articleno    = {abstract O-217},
  author       = {Vanlerberghe, Veerle and Gerstl, S and Guerin, P and Meheus, F and Diap, G and Van Der Stuyft, Patrick and Boelaert, Marleen},
  booktitle    = {Medicine and health in the tropics : abstract book},
  language     = {eng},
  location     = {Marseille, France},
  pages        = {abstract O-217:81--abstract O-217:82},
  title        = {Cost-effectiveness analysis of current first-line drug regimens for visceral leishmaniasis},
  url          = {http://www.festmih.eu/document/1146},
  year         = {2005},
}